↓ Skip to main content

Cochrane Database of Systematic Reviews

Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients

Overview of attention for article published in Cochrane database of systematic reviews, December 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

blogs
1 blog
twitter
12 X users
facebook
1 Facebook page
wikipedia
8 Wikipedia pages
f1000
1 research highlight platform

Citations

dimensions_citation
110 Dimensions

Readers on

mendeley
295 Mendeley
citeulike
2 CiteULike
Title
Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients
Published in
Cochrane database of systematic reviews, December 2012
DOI 10.1002/14651858.cd004388.pub6
Pubmed ID
Authors

Arturo J Martí‐Carvajal, Ivan Solà, Christian Gluud, Dimitrios Lathyris, Vidhu Anand

Abstract

Sepsis is a common and frequently fatal condition. Human recombinant activated protein C (APC) has been introduced to reduce the high risk of death associated with severe sepsis or septic shock. This systematic review is an update of a Cochrane review originally published in 2007.

X Demographics

X Demographics

The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 295 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Denmark 2 <1%
India 1 <1%
Colombia 1 <1%
Canada 1 <1%
Spain 1 <1%
Unknown 289 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 44 15%
Student > Bachelor 36 12%
Student > Ph. D. Student 31 11%
Researcher 26 9%
Student > Postgraduate 21 7%
Other 62 21%
Unknown 75 25%
Readers by discipline Count As %
Medicine and Dentistry 115 39%
Nursing and Health Professions 21 7%
Social Sciences 14 5%
Biochemistry, Genetics and Molecular Biology 12 4%
Pharmacology, Toxicology and Pharmaceutical Science 12 4%
Other 33 11%
Unknown 88 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 August 2020.
All research outputs
#2,018,746
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#4,258
of 11,499 outputs
Outputs of similar age
#17,935
of 286,552 outputs
Outputs of similar age from Cochrane database of systematic reviews
#60
of 190 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 286,552 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 190 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.